Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of human fecal samples for use in animal models intended to support pharmaceutical companies and clinical research organizations. The company's biobank of intestinal microbiomes are used for testing and developing new drugs, facilitates the evaluation of the human gut microbiome in drug and biomarker development as well as evaluates new products targeting the gut microbiome, enabling pharmaceutical companies and clinical research organizations to use the human gut microbiome when testing and developing new drugs and medicine.
You’re viewing a free company profile from the PitchBook Platform. To explore BiomCare’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 18-Jan-2018 | Completed | Generating Revenue |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
Accelerace | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
INCUBA | Accelerator/Incubator | 000 0000 | 000000 0 |